Blog.

Cellular immunotherapy to cope with Covid-19

At Inveniam Group, we would like to congratulate Dr. Rafael Correa Rocha, head of the Immune-Regulation Laboratory of Gregorio Marañón Hospital, for participating in a European consortium that promotes research on cellular immunotherapies to cope with Covid-19. The consortium is coordinated by the Hospital Clínic de Barcelona – IDIBAPS with support of the company Cellnex Telecom.

Miwendo wins 2.8M€ funding of the EIC Accelerator

We are happy to announce that our colleagues from MiWendo Solutions have received a total of 2.8M€ funding from the EIC Accelerator (ex SME Instrument Phase 2). Thanks to this funding, the company can now clinically validate its technology at the Hospital Clínic de Barcelona and begin its industrialization.  MiWEndo Solutions is a medical start-up focused…

INCUBIS H2020 Project Kick-Off

Inveniam Group is delighted kick-off the INCUBIS H2020 project last week to promote #IndustrialSymbiosis in the EU. The three-year EU funded project will establish five regional Incubators in Barcelona, Hull, Norway, Dunkirk and North Germany, to facilitate…

Albert Cot on Capital Cell interviews

As part of Capital Cell interviews of #LifeAfterCovid, our partner Albert Cot shares his view on how the world will be after the coronavirus crisis and how this pandemic will transform the way we do business. Albert emphasizes that the health system is a basic system that needs to be strengthened and it is one…

Successful Ventures invests in Devicare

Inveniam has advised Devicare in the round and the closing of a successful transaction with Successful Ventures.
Successful Ventures is a business angels network with more than 100 active investors. In 2019, it has invested 1.8 million euros in 15 technology-based start-ups, and now is starting its journey in the e-health sector with the help of the leading Spanish company in urology, Devicare.

ZeCardio an investment for the heart

ZeClinics Therapeutics is a biopharmaceutical company focused on the development of treatments for cardiovascular diseases. Nowadays cardiovascular diseases are the cause of death of at least a third of the global population. Despite this issue, there is not enough research on this area because all the focus is on fighting cancer.  ZeClinics proposes a revolutionary…

EIC Accelerator call for “green deal” start-ups and SMEs

It has been confirmed that 19 May ’20 will be a one-off EIC Accelerator call for game-changing green innovation and woman-led start-ups and SMEs. All applicants will have to demonstrate their green credentials and explain how their innovation contributes to the goals of The European Green Deal.